A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma is a research paper published in Neuro-Oncology Advances (2022). On theSindex it has a DataRank of 0. It has been cited 41 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NCI R01 CA214557
BRP NIBIB
Grant: U01 EB028145
BRP NIBIB
Grant: R01 EB016064
BRP NIBIB
Grant: F30CA206291
BRP NIBIB
Grant: F31CA247564-02
NCI NIH HHS
Grant: R01 CA214557
NCI NIH HHS
Grant: F31 CA247564
National Institutes of Health
Grant: 2R01EB016064-05A1
Development and Maintenance of Software for MR Spectroscopic Imaging
National Institutes of Health
Grant: 1F31CA247564-01
Automated imaging analysis tools to guide clinical decision making in brain tumor patients
National Institutes of Health
Grant: 1U01EB028145-01
Improved Whole-Brain Spectroscopic MRI for Radiation Treatment Planning
National Institutes of Health
Grant: 5F30CA206291-03
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
National Institutes of Health
Grant: 5R01CA214557-03
Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients
FWCI
5.17
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals